doi: 10.1007 formulas. J Pediatr Gastroenterol Nutr. 1999 Mar;28(3):270 ... 1007/s40264-015-0350-4. önce 50-60'a, sonrasında da 75-80'e çıkması sonrası
ちょっと前の総説があります
Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions highlight ongoing concerns and research about adjuvants like aluminum salts and oil emulsions, with participants frequently referencing specific studies and safety debates. This indicates a moderate to high level of engagement and acknowledgment of the importance of safety, using technical language and citing previous investigations, suggesting these discussions may influence future research directions and public understanding.
Most discussions acknowledge the importance of safety evaluation of vaccine adjuvants, reflecting a general consensus on the subject's significance.
Participants show moderate curiosity, often mentioning recent research, safety concerns, and debates, indicating a fair level of engagement.
Many comments reference specific studies, chemical components like aluminum, and research history, showing deep involvement and analysis.
Discussions could influence public perception and policy debates about vaccine safety, given their technical details and focus on potential risks.
ちょっと前の総説があります
10/ Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs https://t.co/1LL2c6GcS5
14th Feb > 5th March 2 different products. Novavax started rolling out on the 14th of Feb. The typical adverse reactions we are seeing from Novavax are most likely from the saponin adjuvant, as explained by @vaxine_news paper published 7 years ago. https://t.co/XN3unzMLO1 https://t.co/6jcwfeklUa
@CaryDavid722 @richykirsh @higgsri @Lorenzo7127 @PatrickSquirrel @DopplerEffect93 @crabb_vicki @trillionofcells @deerbrian @mass_rising @Earthdriver @ChrisJohnsonMD @SkepticalMutant @exohalophiles @DemsRRacePimps @Monstercoyliar @BlueLionBlog @Rand73696477 @FillmoreWhite @BurgerLab12 @CarlSmytheCells @Scary7Dr @Alex_on_A14 @jtmayes3 @cappsie @The_Seeadler @AndrewLazarus4 @ncdave4life @TMGFlorida @Roper_Lab @ktibus @SecedeFromFools @TorySnyc @dirk_fasshauer @RonMortimer3 @mcfunny @lasikeyecenter1 @Hanky1844607 @davideyoungmd @Awithonelison @NoGlobalist778 @EugeneBu @AcampbelTeacher @EdwardDS15 @VickiCoyle10019 @FUDyou2 @smith_john55 @TheCrystalBrian @ScooterScience @RndmStreetMedic I'm not saying Aluminum is not neurotoxic, it is. It does not belong in the brain and the body has defenses against it. Yes, some will cross the BBB and that is worth examining. We might choose a worse adjuva
@Lisa_BB81 @Etienne_Chouard https://t.co/zcvW2CNbRG https://t.co/7szHBZqLFU Merci de ta participation. C'était 3 minutes sur google scholar. https://t.co/8aqVmYxPUj
@ScienceNvrSttld @radswan1 Its even worse. From my understanding its solely the RBD of the spike (which we know is now heavily mutated) + MF59 adjuvant... Again @vaxine_news adjuvant paper 7 YEARS AGO details the concerns of using that specific type of adjuvant.. https://t.co/fKdLVXWBlV https://t.co/gZOleP7Pkq
This video discusses aluminum in vaccines and its potential connection to Alzheimer's disease. It examines how aluminum enters the human body, its accumulation in the brain, and whether it could contribute to…
This video discusses the role of aluminum in vaccines, highlighting scientific evidence showing no link between aluminum exposure and chronic childhood disorders.
RT @teacher3cp0: @liz_churchill10 Animal models show that some adjuvants, especially oil emulsions and aluminium salts, can trigger autoimm…
@liz_churchill10 https://t.co/G4qaCb37jY https://t.co/4zkr4D7iUv https://t.co/0583C2QzKj https://t.co/Tm6bTfQPLM https://t.co/3nollQpe0t https://t.co/k9bJWPV10M https://t.co/URFgFXaZa4 https://t.co/fx7JvMHYyF https://t.co/dfmRBsJVUv
@liz_churchill10 Animal models show that some adjuvants, especially oil emulsions and aluminium salts, can trigger autoimmune diseases, chronic inflammation, and neurotoxicity-raising concerns about long-term safety and genetic susceptibility https://t.co/G4qaCb37jY
RT @IntegralAnswers: 10/ Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs https://t.co/1LL2c6GcS5
RT @IntegralAnswers: 10/ Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs https://t.co/1LL2c6GcS5
RT @IntegralAnswers: 10/ Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs https://t.co/1LL2c6GcS5
RT @IntegralAnswers: 10/ Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs https://t.co/1LL2c6GcS5
10/ Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs https://t.co/1LL2c6GcS5
@HamHead5813 @AJazzmom98 @WendyHassonMD What’s wrong? Can’t answer the question? https://t.co/y2qOJGPcHd Also https://t.co/s5irbYqIQ0
@CaryDavid722 @richykirsh @higgsri @Lorenzo7127 @PatrickSquirrel @DopplerEffect93 @crabb_vicki @trillionofcells @deerbrian @mass_rising @Earthdriver @ChrisJohnsonMD @SkepticalMutant @exohalophiles @DemsRRacePimps @Monstercoyliar @BlueLionBlog @Rand73696477 @FillmoreWhite @BurgerLab12 @CarlSmytheCells @Scary7Dr @Alex_on_A14 @jtmayes3 @cappsie @The_Seeadler @AndrewLazarus4 @ncdave4life @TMGFlorida @Roper_Lab @ktibus @SecedeFromFools @TorySnyc @dirk_fasshauer @RonMortimer3 @mcfunny @lasikeyecenter1 @Hanky1844607 @davideyoungmd @Awithonelison @NoGlobalist778 @EugeneBu @AcampbelTeacher @EdwardDS15 @VickiCoyle10019 @FUDyou2 @smith_john55 @TheCrystalBrian @ScooterScience @RndmStreetMedic I'm not saying Aluminum is not neurotoxic, it is. It does not belong in the brain and the body has defenses against it. Yes, some will cross the BBB and that is worth examining. We might choose a worse adjuva
RT @lonnibesancon: @Lisa_BB81 @Etienne_Chouard https://t.co/zcvW2CNbRG https://t.co/7szHBZqLFU Merci de ta participation. C'était 3 minut…
@Lisa_BB81 @Etienne_Chouard https://t.co/zcvW2CNbRG https://t.co/7szHBZqLFU Merci de ta participation. C'était 3 minutes sur google scholar. https://t.co/8aqVmYxPUj
@catsscareme2021 Molybdenum and Zirconium are also used in adjuvants. https://t.co/ItXBM1Gl8v https://t.co/MpABpHcvnc
Petrovsky (2015) Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs with 160 references https://t.co/w3gPydJEF6
@PhilipRafferty5 @Beck_Sall @lawrie_dr https://t.co/WJNDZapkAe It took literally 2sec to find. Your research skills are shambolic.
@Homer2331 @fun_g4l @AdriftInSLC @matthewwell https://t.co/huIgybo3gE
@ScienceNvrSttld @radswan1 Its even worse. From my understanding its solely the RBD of the spike (which we know is now heavily mutated) + MF59 adjuvant... Again @vaxine_news adjuvant paper 7 YEARS AGO details the concerns of using that specific type of adjuvant.. https://t.co/fKdLVXWBlV https://t.co/gZOleP7Pkq
RT @CgaProdigy: 14th Feb > 5th March 2 different products. Novavax started rolling out on the 14th of Feb. The typical adverse reactions…
14th Feb > 5th March 2 different products. Novavax started rolling out on the 14th of Feb. The typical adverse reactions we are seeing from Novavax are most likely from the saponin adjuvant, as explained by @vaxine_news paper published 7 years ago. https://t.co/XN3unzMLO1 https://t.co/6jcwfeklUa
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs https://t.co/3bQzVICg80
RT @minesoh: ちょっと前の総説があります
ちょっと前の総説があります
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs https://t.co/pDQn3f1mmC
@colony_rant @PeterBaulch @ottawahealth Additionally each study is not from the 60s as you claim, most are the 90s. Looking for more recent summary, https://t.co/gIf7v6dfyF Or continuing innovation, https://t.co/J8NtkeUfHJ
@JMLeitch @Reuters @BorisJohnson 1. This is a legal blog; *hardly* an unbiased appraisal. I'm not going to engage with this kind of 'evidence'. 2. It wasn't 'spiked'. BOTH an aluminium adjuvant and a saline solution were used as placebos. 3. Said aluminium adjuvant's are very safe: https://t.co/rcyRL4Jx4e.
@WendyOrent @LifeDorr @fiski70 @drchriscole @AntivaxNi66a @kfunk937 @BeckyJohnson222 @EdDarrell @SkepticalASDMom @badzoot7 @LauraDekker1 @Monstercoyliar @ianfmusgrave @MacBaird13 @DreadPirRob42 @David_5705 @MyxaZZ @StopVaxxedLies @_mamadeb @TakeThatCDC @LenGrunstein @SmilesbyPayet @BlueLionBlog @SocialHermitCal @lawnatural @krebiozen @Juanita87722370 @MarkSchirmer4 @QuatloosX @Awithonelison @Sheldon_Walker_ @jp_miner @mcfunny @JaneEOpie @jkellyca @TThoughtmonger @doritmi @Boxmenot @immunotoxPhD @MAhealthforkids @TioChango_ @saluce65 @kuriousmind93 @downeyballs @AndrewLazarus4 @asiamoonbloom @VeritasEver @thereal_truther @rugbyrhino16 @ghoppe Here: https://t.co/HlkQBDEpkH https://t.co/ki1OgtZinh
@MaryanneDemasi @ProfTimNoakes @DrEades @eatmostlyfatali @FatEmperor @PGtzsche1 @drjoesDIYhealth @FructoseNo @drjasonfung @zoeharcombe @fgodlee “especially because AAHS is reported to have a harm profile.” Shall we look at the paper which appears to be the basis of this claim? https://t.co/u8zAIOLPRX https://t.co/etsjUDTRm1
@Charbrevolution @SoSBega @NagelBernhard @ProfTimNoakes @AlastairMcA30 @FULLBORECRNVORE @LaLaRueFrench75 Here's one review to read: https://t.co/5yh4Rdw2vh You do realize that we are exposed to aluminum in many different ways. Better not feed kids cheese either: https://t.co/CzglehMnzg Or other foods? https://t.co/TJoIoLCFKL Or maybe even tea https://t.co/FqF4ymeTeQ
@Charbrevolution @SoSBega @ProfTimNoakes @NagelBernhard @AlastairMcA30 @FULLBORECRNVORE @LaLaRueFrench75 https://t.co/5yh4Rdw2vh
@sachkadabra @DuvergeDavid @Djedje06600 @Iguanas00110527 @gouvernementFR Non. https://t.co/T0rYtvEF5E De rien.
@SceaMarcoou @itinerisFred Donc plutôt que Gherardi qui s'associe en plus avec des groupes antivaxx : https://t.co/KZYyZeKawZ https://t.co/vJwPoSVw6q https://t.co/T0rYtvEF5E
@PaulPoras @Ignis87736341 @ChampoDr @ericbrunet Pour votre lecture, voici également deux revues de la littérature sur les dangers de l'aluminium dans des vaccins. C'est un peu plus technique que des vidéos youtube mais vous devriez vous en sortir, la conclusion est très claire. https://t.co/KZYyZeKawZ https://t.co/T0rYtvEF5E
doi: 10.1007 formulas. J Pediatr Gastroenterol Nutr. 1999 Mar;28(3):270 ... 1007/s40264-015-0350-4. önce 50-60'a, sonrasında da 75-80'e çıkması sonrası
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...
DOI: 10.1007/s40264-015-0350-4 3. Principi & Esposito, 2018 – Vaccine Revue clinique internationale → aucune preuve crédible d'un risque ...